Preston Rober Tisch Brain Tumor Center

Two of Three CTSA TL1 Post-Doc Training Program Awards Go to 2 Cancer Scientists

Two of the 3 fellows selected to receive Duke CTSA TL1 Post-Doctoral Training Program Award this month are engaged in cancer-related research.

March 25, 2021

DCI Research

Recurrent GBM Brain Tumors with Few Mutations Respond Best to Immunotherapy

The finding from a genetic analysis of tumors treated with Duke’s poliovirus therapy suggests a predictive biomarker for survival.

January 13, 2021

DCI Research

January Newsmakers

CDC urges boys, girls get HPV vaccine earlier (WRAL) Features Steven Patierno, PhD Developing New Strategies for Cancer Drug Delivery, in Denmark ...

January 10, 2017

In the News

Angels Among Us Raises Record $2.3 Million

More than 4,000 participants attended the 25th Annual Angels Among Us 5K on Saturday, April 28. Together, they raised a record $2.3 million to support...

April 30, 2018

Announcements Special Events

Newly Identified Genetic Markers Classify Previously Undetermined GBM Tumors

Most glioblastoma tumors are marked by one or two broad mutation patterns, but about 20 percent of the lethal brain tumors have biomarkers that cannot...

June 5, 2018

DCI Research Announcements

He's Just Gotta Run

Marathon runner Tom O’Donnell says he doesn’t run to go fast. He says he has a battle on his hands and he’s got to be in the best shape possible if he...

November 23, 2016

Special Events Patient Stories